Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT02343991	TitleBlood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound	Fase No aplicable	Date Added 2015-01-22	Ubicación Canadá	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Transcranial ExABlate	Etiquetas MSS/ MMRp
NCT ID NCT02298959	TitleTesting the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer	Fase Fase 1	Date Added 2014-11-24	Ubicación Florida, United States Maryland, United States Massachusetts, United States Canadá	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Pembrolizumab, Ziv-Aflibercept, Keytruda, Zaltrap	Etiquetas MSS/ MMRp
NCT ID NCT02285816	TitleMG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours	Fase Phase 1, Phase 2	Date Added 2014-11-07	Ubicación Canadá	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas AdMA3, MG1MA3	Etiquetas MSS/ MMRp
NCT ID NCT02215889	TitleEstudio de trasplante parcial del segmento hepático 2/3	Fase Fase 1	Date Added 2014-08-13	Ubicación Noruega	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT01697371	TitleLa terapia de protones en el tratamiento de las metástasis hepáticas	Fase No aplicable	Date Added 2012-10-02	Ubicación California, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT01351103	TitleA Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands	Fase Fase 1	Date Added 2011-05-10	Ubicación California, United States Maryland, United States Massachusetts, United States Michigan, United States Texas, United States Canadá Francia Alemania Italia Países Bajos España	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas LGK974, PDR001	Etiquetas MSS/ MMRp
NCT ID NCT01174121	TitleImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer	Fase Fase 2	Date Added 2010-08-03	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Aldesleukin, Cyclophosphamide, Fludarabine, Pembrolizumab (Keytruda), Young TIL	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT01061515	TitleBiweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer	Fase Fase 1	Date Added 2010-02-03	Ubicación Missouri, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Bevacizumab, capecitabine, Intraperitoneal Oxaliplatin, Avastin, Eloxatin, Xeloda	Etiquetas MSS/ MMRp
NCT ID NCT00001823	TitleEvaluation for NCI Surgery Branch Immunotherapy Clinical Research Protocols	Fase	Date Added 1999-11-04	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 291 to 299 of 299 entries